| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 23.896 | 32.569 | 39.515 | 45.186 | 46.203 | 45.910 | 56.184 | 76.459 | 92.027 |
| Total Income - EUR | 0 | 23.896 | 32.569 | 39.515 | 45.187 | 47.237 | 45.910 | 56.185 | 76.460 | 92.273 |
| Total Expenses - EUR | 531 | 14.811 | 23.020 | 25.179 | 27.016 | 27.595 | 30.422 | 27.991 | 32.189 | 39.876 |
| Gross Profit/Loss - EUR | -531 | 9.085 | 9.549 | 14.336 | 18.170 | 19.642 | 15.489 | 28.194 | 44.270 | 52.397 |
| Net Profit/Loss - EUR | -531 | 8.806 | 9.223 | 13.941 | 17.718 | 19.215 | 15.030 | 27.632 | 43.597 | 49.961 |
| Employees | 0 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Astramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 100 | 31 | 5 | 0 | 502 | 730 | 942 | 3.089 | 15.547 | 12.069 |
| Current Assets | 285 | 8.763 | 9.727 | 15.711 | 18.442 | 19.728 | 15.982 | 28.457 | 29.283 | 40.148 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 2.182 | 2.364 | 3.203 | 3.656 | 4.284 | 5.000 | 25.387 | 16.884 | 30.891 |
| Cash | 285 | 6.581 | 7.362 | 12.507 | 14.787 | 15.444 | 10.982 | 3.070 | 12.399 | 9.257 |
| Shareholders Funds | -486 | 8.325 | 9.276 | 13.992 | 17.769 | 19.264 | 15.078 | 27.681 | 43.706 | 50.529 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 871 | 479 | 466 | 1.855 | 1.189 | 1.206 | 1.858 | 3.879 | 1.473 | 1.697 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Astramed Srl